VICTOR MANUEL
VICTOR GONZALEZ
TITULAR DE UNIVERSIDAD
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (26)
2024
-
Correction to: Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells (Cell Death & Disease, (2020), 11, 5, (339), 10.1038/s41419-020-2558-1)
Cell Death and Disease
-
Interference with mitochondrial function as part of the antifibrogenic effect of Rilpivirine: A step towards novel targets in hepatic stellate cell activation
Biomedicine and Pharmacotherapy, Vol. 178
2023
-
Anti-inflammatory and immunomodulating effects of rilpivirine: Relevance for the therapeutics of chronic liver disease
Biomedicine and Pharmacotherapy, Vol. 167
-
Mitochondrial Dysfunction and Mitophagy in Type 2 Diabetes: Pathophysiology and Therapeutic Targets
Antioxidants and Redox Signaling, Vol. 39, Núm. 4-6, pp. 278-320
2022
-
Cerium dioxide nanoparticles modulate antioxidant defences and change vascular response in the human saphenous vein
Free Radical Biology and Medicine, Vol. 193, pp. 694-701
-
Gold Nanoparticles Supported on Ceria Nanoparticles Modulate Leukocyte–Endothelium Cell Interactions and Inflammation in Type 2 Diabetes
Antioxidants, Vol. 11, Núm. 11
-
Impact of nitric oxide in liver cancer microenvironment
Nitric Oxide - Biology and Chemistry, Vol. 128, pp. 1-11
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Micrornas and oxidative stress: An intriguing crosstalk to be exploited in the management of type 2 diabetes
Antioxidants, Vol. 10, Núm. 5
-
Testosterone administration increases leukocyte-endothelium interactions and inflammation in transgender men
Fertility and Sterility, Vol. 115, Núm. 2, pp. 483-489
-
Therapeutic implications of targeting antioxidants to mitochondria
Mitochondrial Dysfunction and Nanotherapeutics: Aging, Diseases, and Nanotechnology-Related Strategies in Mitochondrial Medicine (Elsevier), pp. 459-475
-
Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet?
Journal of Pathology, Vol. 254, Núm. 3, pp. 216-228
2020
-
Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells
Cell Death and Disease, Vol. 11, Núm. 5
-
Integrated molecular signaling involving mitochondrial dysfunction and alteration of cell metabolism induced by tyrosine kinase inhibitors in cancer
Redox Biology, Vol. 36
-
Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions
Redox Biology, Vol. 34
-
Mitochondria and T2D: Role of Autophagy, ER Stress, and Inflammasome
Trends in Endocrinology and Metabolism, Vol. 31, Núm. 10, pp. 725-741
2019
-
Mitophagy in human astrocytes treated with the antiretroviral drug Efavirenz: Lack of evidence or evidence of the lack
Antiviral Research, Vol. 168, pp. 36-50
2018
-
Mitochondria, the NLRP3 inflammasome, and sirtuins in type 2 diabetes: New therapeutic targets
Antioxidants and Redox Signaling, Vol. 29, Núm. 8, pp. 749-791
2016
-
The purine analogues abacavir and didanosine increase acetaminophen-induced hepatotoxicity by enhancing mitochondrial dysfunction
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 4, pp. 916-926
2015
-
Mitochondrial (dys)function - A factor underlying the variability of efavirenz-induced hepatotoxicity?
British Journal of Pharmacology, Vol. 172, Núm. 7, pp. 1713-1727